PRESS RELEASE published on 09/25/2024 at 22:01, 1 year 5 months ago Abivax fait le point sur la stratégie du programme de traitement combiné dans la RCH et annonce les données précliniques précoces de combinaison d’obefazimod et d’étrasimod dans un modèle murin MICI Abivax annonce des données précliniques de combinaison d'obefazimod et d'étrasimod dans un modèle murin MICI pour traiter la RCH. Prochaine publication au T4 2024 Abivax Obefazimod Etrasimod Traitement Combiné RCH
BRIEF published on 09/19/2024 at 18:05, 1 year 6 months ago ABIVAX : Nombre d’actions et droits de vote au 31 août 2024 Euronext Paris Droits De Vote Capital Social Biotechnologie Abivax
BRIEF published on 09/19/2024 at 18:05, 1 year 6 months ago ABIVAX: Number of shares and voting rights as of August 31, 2024 Euronext Paris Share Capital Voting Rights Biotechnology Abivax
PRESS RELEASE published on 09/19/2024 at 18:00, 1 year 6 months ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.08.24. ABIVAX communique sur le nombre d'actions et de droits de vote au 31.08.24, conformément aux dispositions réglementaires. Société biotechnologique spécialisée en traitements thérapeutiques innovants Droits De Vote Capital Social Biotechnologie Abivax Traitements Thérapeutiques
BRIEF published on 09/09/2024 at 23:01, 1 year 6 months ago Déclaration de Marc de Garidel sur le Rapport Financier Semestriel 2024 d'Abivax Abivax Transparence IFRS Rapport Financier Patrimoine
BRIEF published on 09/09/2024 at 23:01, 1 year 6 months ago Statement by Marc de Garidel on Abivax's 2024 Half-Year Financial Report Financial Report Abivax Transparency IFRS Heritage
PRESS RELEASE published on 09/09/2024 at 22:56, 1 year 6 months ago Attestation du responsable du Rapport financier semestriel 2024 Déclaration de la personne responsable du rapport financier intermédiaire pour le semestre écoulé conforme aux normes IFRS, présentant une image fidèle de la société Déclaration Rapport Financier Normes IFRS Semestre Personne Responsable
PRESS RELEASE published on 09/09/2024 at 22:53, 1 year 6 months ago Rapport des CAC sur l'information financière semestrielle 2024
PRESS RELEASE published on 09/09/2024 at 22:43, 1 year 6 months ago Rapport CAC sur l'information financière semestrielle 2024
BRIEF published on 09/09/2024 at 22:40, 1 year 6 months ago ABIVAX présente ses résultats semestriels 2024 Résultats Semestriels Abivax Cybersécurité Contrôle Interne Défaillances
Published on 03/23/2026 at 14:05, 1 hour 46 minutes ago Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 14:00, 1 hour 51 minutes ago BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
Published on 03/23/2026 at 13:05, 2 hours 46 minutes ago SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 12:32, 3 hours 19 minutes ago Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 12:30, 3 hours 21 minutes ago Digi Power X to Announce 2025 Year End Financial Results on March 31st
Published on 03/23/2026 at 15:05, 46 minutes ago Heidrick & Struggles Launches Heidrick Immersive, an AI-Enhanced Platform for Observing Leadership in Motion
Published on 03/23/2026 at 14:41, 1 hour 10 minutes ago CEWE increases dividend for 17 consecutive years
Published on 03/23/2026 at 14:30, 1 hour 21 minutes ago Solvias Earns EcoVadis Bronze Medal, Ranking in Top 35% of Companies for Sustainability Performance
Published on 03/23/2026 at 14:30, 1 hour 21 minutes ago Belvilla Expands in Germany with Hambachtal Holiday Park in Oberhambach
Published on 03/23/2026 at 14:24, 1 hour 27 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 03/23/2026 at 08:10, 7 hours 41 minutes ago Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 20 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 20 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 21 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 21 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA